Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%
Aesthetic Surgery Journal · 2023
DOI: 10.1093/asj/sjad076 ↗Kurz gefasst
Editorial in der Zeitschrift Aesthetic Surgery Journal, 2023. Verfasst von Jean Carruthers. Hauptthemen laut MEDLINE: Blepharoptosis, Clostridium botulinum, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Jean Carruthers
Zitieren
APA
Carruthers, J. (2023). Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjad076
Vancouver
Carruthers J. Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%. Aesthetic Surgery Journal. 2023. doi:10.1093/asj/sjad076
BibTeX
@article{Carruthers2023,
author = {Carruthers, Jean},
title = {Commentary on: Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1%},
journal = {Aesthetic Surgery Journal},
year = {2023},
doi = {10.1093/asj/sjad076}
}
EUVIMED